Wanbury Limited
NSE:WANBURY.NS
230.17 (INR) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Wanbury Limited |
Symbool | WANBURY.NS |
Munteenheid | INR |
Prijs | 230.17 |
Beurswaarde | 7,540,484,285 |
Dividendpercentage | 0% |
52-weken bereik | 87.9 - 290.2 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. K. Chandran |
Website | https://www.wanbury.com |
An error occurred while fetching data.
Over Wanbury Limited
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)